Abstract

Accelerate Your Drug Discovery Process with Maybridge Screening Collections and Fragment Libraries

Simon Pearce, Global Product Manager, ThermoFisher Scientific

•The search for bioactive molecules in early-stage drug discovery using rapid compound screening and fragment-based design should not be like looking for a needle in a haystack. Selecting a highly diverse screening collection containing many drug-like compounds can reduce the element of chance and shorten the drug discovery process. •For over 50 years, Maybridge has been at the forefront of innovative screening compound design, fuelled by the desire to access novel molecules of pharmaceutical interest. •The Maybridge portfolio is driven by a keen understanding of the needs of the drug discovery scientist and designed to expedite the drug discovery process.